• OncologyTube
    • 0
      • Title
        User LIVE NOW
      • LIVE NOW
        Title
        User
        • Sign In
    • Home
    • Trending

    • Sign In

    • Audios and Videos
    • Videos
    • Audios

    • Channels

    • Browse Channels

    • Categories

    • Acute Lymphoblastic Leukemia 5637
    • Acute Myelogenous Leukemia 149
    • Bladder Cancer 49
    • Bone Metastases 1
    • Brain Cancer 16
    • Breast Cancer 120
    • Business Management 2
    • Cervical Cancer 2
    • Chronic Lymphocytic Leukemia 148
    • Chronic Myelogenous Leukemia 20
    • Colorectal Cancer 75
    • Gastrointestinal Cancer 70
    • General 244
    • Head and Neck Cancers 34
    • Hematologic Malignancies 79
    • Hodgkin Lymphoma 18
    • Immunotherapy 86
    • Kidney Cancer 364
    • Liver Cancer 11
    • Lymphoma 145
    • Melanoma and Skin Cancer 51
    • Multiple Myeloma 336
    • Myeloproliferative Disease 15
    • News 115
    • Non-Hodgkin Lymphoma 44
    • Non-Small Cell Lung Cancer 267
    • Other 110
    • Ovarian Cancer 10
    • Pancreatic Cancer 54
    • Patient Resources 27
    • Prostate Cancer 148
    • Small Cell Lung Cancer 58
    • Soft Tissue Sarcoma 9
    • Supportive Care 38
    • Testicular Cancer 2
    • Urology 6
    • Uterine Cancer 2

    • About
    • Contact
    What Is the Life Span and Quality of Life for a Patient With Essential Thrombocythemia?
    00:02:04

    What Is the Life Span and Quality of Life for a Patient With Essential Thrombocythemia?

    What is the expected life span and quality of life for a patient diagnosed with essential thrombocythemia (ET)? In this Ask the Expert segment, Dr. Prithviraj Bose from The University of Texas MD Anderson Cancer Center discusses reviews the typical monitoring and risks of ET and refers to the diagnosis as the most favorable prognosis among the classic MPN diagnoses. Get email alerts | http://www.patientpower.info/alerts Subscribe on YouTube | http://www.youtube.com/patientpower Like on Facebook | http://www.fb.com/patientpower.info Follow on Twitter | http://www.twitter.com/patientpower Follow on Google+ | http://www.google.com/+patientpowerinfo

    Acute Lymphoblastic Leukemia
    759 Views
    3 years ago
    P2Professional
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Live

    Trending

    Avelumab, for Metastatic Merkel Cell Carcinoma | Observed Responses are Durable
    00:01:27

    Avelumab, for Metastatic Merkel Cell Carcinoma | Observed Responses are Durable

    Melanoma and Skin Cancer
    130 Views
    1 year ago
    Annual-Meeting
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    First Line Therapy In cMRCC
    00:01:43

    First Line Therapy In cMRCC

    Kidney Cancer
    47 Views
    1 year ago
    kidneycancer
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    ADD - Should myeloma patients stay on maintenance therapy for several years?
    00:03:10

    ADD - Should myeloma patients stay on maintenance therapy for several years?

    Acute Lymphoblastic Leukemia
    154 Views
    1 year ago
    InternationalMyelomaFoundation
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    The rarer toxicities of immunotherapy
    00:00:42

    The rarer toxicities of immunotherapy

    Acute Lymphoblastic Leukemia
    151 Views
    1 year ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    What’s Next for Entrectinib?
    00:00:52

    What’s Next for Entrectinib?

    Acute Lymphoblastic Leukemia
    367 Views
    2 years ago
    AnnualMeeting2017
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Ethicon: Providing Research on Minimally Invasive Treatment Options for Patients with Lung Cancer

    Ethicon: Providing Research on Minimally Invasive Treatment Options for Patients with Lung Cancer

    Acute Lymphoblastic Leukemia
    4 Views
    3 years ago
    News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    ELCC 2016: Acquired resistance to third-generation EGFR TKIs in NSCLC
    00:01:47

    ELCC 2016: Acquired resistance to third-generation EGFR TKIs in NSCLC

    Acute Lymphoblastic Leukemia
    365 Views
    3 years ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Anti-BCMA CAR T-cells for MM: durable clinical responses with bb2121
    00:03:16

    Anti-BCMA CAR T-cells for MM: durable clinical responses with bb2121

    Acute Lymphoblastic Leukemia
    152 Views
    1 year ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    ProVent Trial: When Will There Be Results? ProVent Trial: When Will There Be Results?
    0:02:45

    ProVent Trial: When Will There Be Results?

    Prostate Cancer
    4 Views
    3 weeks ago
    CURC
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    RANGO: establishing a rare gynecological tumor database to improve future care
    00:02:39

    RANGO: establishing a rare gynecological tumor database to improve future care

    General
    105 Views
    1 year ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Mechanisms of Resistance to EGFR TKI and New Treatment Strategies
    00:21:08

    Mechanisms of Resistance to EGFR TKI and New Treatment Strategies

    Acute Lymphoblastic Leukemia
    386 Views
    3 years ago
    imedex
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Dana-Farber IFM Study Data
    00:00:46

    Dana-Farber IFM Study Data

    Multiple Myeloma
    153 Views
    1 year ago
    imedex
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Latest Videos

    Phase 3 ICARIA-MM trial of isatuximab #ASH19 #ASH @sanofi Phase 3 ICARIA-MM trial of isatuximab #ASH19 #ASH @sanofi
    0:02:54

    Phase 3 ICARIA-MM trial of isatuximab #ASH19 #ASH @sanofi

    Multiple Myeloma
    0 Views
    6 hours ago
    ash
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CARTITUDE-1: How is This Different from Others? @MountSinaiNYC @DMadduri #ASH19 #ASH CARTITUDE-1: How is This Different from Others? @MountSinaiNYC @DMadduri #ASH19 #ASH
    0:02:11

    CARTITUDE-1: How is This Different from Others? @MountSinaiNYC @DMadduri #ASH19 #ASH

    Multiple Myeloma
    2 Views
    7 hours ago
    ash
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528 @MountSinaiNYC @DMadduri CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528 @MountSinaiNYC @DMadduri
    0:03:15

    CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528 @MountSinaiNYC @DMadduri

    Multiple Myeloma
    2 Views
    7 hours ago
    ash
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CAR-T Cell Imaging Markers: How This Affects Clinicians @PennMedicine CAR-T Cell Imaging Markers: How This Affects Clinicians @PennMedicine
    0:03:47

    CAR-T Cell Imaging Markers: How This Affects Clinicians @PennMedicine

    Immunotherapy
    0 Views
    8 hours ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    How Sensitive is the Technology? @PennMedicine @sellmyerlab How Sensitive is the Technology? @PennMedicine @sellmyerlab
    0:02:38

    How Sensitive is the Technology? @PennMedicine @sellmyerlab

    Immunotherapy
    0 Views
    8 hours ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CAR-T Cells With Imaging Markers @PennMedicine sellmyerlab @sellmyerlab CAR-T Cells With Imaging Markers @PennMedicine sellmyerlab @sellmyerlab
    0:03:30

    CAR-T Cells With Imaging Markers @PennMedicine sellmyerlab @sellmyerlab

    Immunotherapy
    0 Views
    8 hours ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Acute Lymphoblastic Leukemia

    2019 Nobel Prize for Medicine Recipients recognized for Cancer Research  through study of von Hippel-Lindau (VHL) disease

    2019 Nobel Prize for Medicine Recipients recognized for Cancer Research through study of von Hippel-Lindau (VHL) disease

    1 Views
    1 day ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019

    INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019

    5 Views
    1 day ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Phase 1/2 AUGMENT-101 Trial @sloan_kettering Phase 1/2 AUGMENT-101 Trial @sloan_kettering
    0:04:52

    Phase 1/2 AUGMENT-101 Trial @sloan_kettering

    13 Views
    2 weeks ago
    Memorial Sloan Kettering
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Melanoma Rates Decline Found in Younger Population Melanoma Rates Decline Found in Younger Population
    0:03:21

    Melanoma Rates Decline Found in Younger Population

    2 Views
    3 weeks ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias

    Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias

    12 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
    EE:EE:EE

    What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube

    38 Views
    2 months ago
    Stan
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Acute Myelogenous Leukemia

    Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting

    Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting

    2 Views
    1 day ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia

    Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia

    5 Views
    6 days ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment

    Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment

    15 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    How to Manage MDS Patients who are Ineligible for Transplant
    00:01:47

    How to Manage MDS Patients who are Ineligible for Transplant

    300 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    The Recent Wave of Approval in AML
    00:01:54

    The Recent Wave of Approval in AML

    138 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Updated Data on Gilteritinib in AML
    00:01:12

    Updated Data on Gilteritinib in AML

    16 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Bladder Cancer

    EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19 EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
    0:02:13

    EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19

    17 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    EV-103 Phase I Trial Presented at #ESMO19 EV-103 Phase I Trial Presented at #ESMO19
    0:01:45

    EV-103 Phase I Trial Presented at #ESMO19

    24 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer

    Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer

    33 Views
    2 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

    Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

    23 Views
    2 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Strategies for Treating 2nd Line RCC Patients
    00:01:17

    Strategies for Treating 2nd Line RCC Patients

    54 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Treating Newly Diagnosed RCC Patients
    00:02:08

    Treating Newly Diagnosed RCC Patients

    53 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Bone Metastases

    If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
    00:00:40

    If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea

    194 Views
    1 year ago
    Annual-Meeting
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Brain Cancer

    Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

    Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

    5 Views
    2 weeks ago
    alexvarney
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Predicting Tumor Recurrence: How Does This Help Us? Predicting Tumor Recurrence: How Does This Help Us?
    0:03:05

    Predicting Tumor Recurrence: How Does This Help Us?

    7 Views
    1 month ago
    Baylor College of Medicine
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Predicting Tumor Recurrence Predicting Tumor Recurrence
    0:03:36

    Predicting Tumor Recurrence

    20 Views
    1 month ago
    Baylor College of Medicine
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    How does this affect clinicians today? How does this affect clinicians today?
    0:01:20

    How does this affect clinicians today?

    7 Views
    2 months ago
    Cleveland Clinic
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
    0:01:26

    Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells

    15 Views
    2 months ago
    Cleveland Clinic
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Oncoceutics Commemorates National Childhood Cancer Awareness Month

    Oncoceutics Commemorates National Childhood Cancer Awareness Month

    15 Views
    2 months ago
    alexvarney
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Breast Cancer

    CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial

    CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial

    6 Views
    6 days ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju
    0:03:14

    Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju

    2 Views
    1 week ago
    Duke Cancer
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju
    0:02:49

    Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju

    4 Views
    1 week ago
    Duke Cancer
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Who is Eligible for the AVIATOR Study? @SeattleCCA Who is Eligible for the AVIATOR Study? @SeattleCCA
    0:02:08

    Who is Eligible for the AVIATOR Study? @SeattleCCA

    2 Views
    3 weeks ago
    SeattleCCA
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    The AVIATOR Study @SeattleCCA The AVIATOR Study @SeattleCCA
    0:04:33

    The AVIATOR Study @SeattleCCA

    3 Views
    3 weeks ago
    SeattleCCA
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer

    Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer

    8 Views
    1 month ago
    Roswell Park
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Business Management

    Two Sided Payment Agreements & The Risks Involved
    00:01:47

    Two Sided Payment Agreements & The Risks Involved

    116 Views
    11 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    MOASC COAnalyzer Tool Ricky Newton
    01:01:00

    MOASC COAnalyzer Tool Ricky Newton

    99 Views
    1 year ago
    moasc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Cervical Cancer

    Novel revelations in CLL biology with venetoclax/ibrutinib
    00:02:24

    Novel revelations in CLL biology with venetoclax/ibrutinib

    93 Views
    1 year ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Immunotherapy in gynecological cancers: current and future landscape
    00:02:35

    Immunotherapy in gynecological cancers: current and future landscape

    474 Views
    1 year ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Chronic Lymphocytic Leukemia

    New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYXTO® (venetoclax) Combination in Patients with Relapsed/Refrac...

    New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYXTO® (venetoclax) Combination in Patients with Relapsed/Refrac...

    2 Views
    1 day ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Phase 3 DUO Study @ospniguarda Phase 3 DUO Study @ospniguarda
    0:11:36

    Phase 3 DUO Study @ospniguarda

    10 Views
    2 weeks ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
    00:04:47

    ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia

    201 Views
    5 months ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
    00:07:04

    ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs

    92 Views
    5 months ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CLL, What is the significance of IGHV mutations and how are they assessed
    00:02:48

    CLL, What is the significance of IGHV mutations and how are they assessed

    87 Views
    5 months ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Not Your Fathers CLL with Dr. John Pagel
    01:02:14

    Not Your Fathers CLL with Dr. John Pagel

    114 Views
    5 months ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Chronic Myelogenous Leukemia

    Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy
    0:16:51

    Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy

    4 Views
    1 day ago
    iCMLf
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Perspectives on the Future of CML Perspectives on the Future of CML
    0:26:35

    Perspectives on the Future of CML

    2 Views
    1 day ago
    iCMLf
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Re-evaluating TKI in CML Patients During Pregnancy Re-evaluating TKI in CML Patients During Pregnancy
    0:15:04

    Re-evaluating TKI in CML Patients During Pregnancy

    2 Views
    1 day ago
    iCMLf
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CML and Pregnancy CML and Pregnancy
    0:15:30

    CML and Pregnancy

    2 Views
    1 day ago
    iCMLf
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Treating CML & Myelofibrosis Patients
    00:01:34

    Treating CML & Myelofibrosis Patients

    319 Views
    11 months ago
    imedex
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Resistance/intolerance to second generation TKIs in CML: what to do next?
    00:02:14

    Resistance/intolerance to second generation TKIs in CML: what to do next?

    155 Views
    1 year ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Colorectal Cancer

    Are These Gene Fusions Targetable? @katherineclift4 @WUSTL Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
    0:02:35

    Are These Gene Fusions Targetable? @katherineclift4 @WUSTL

    3 Views
    1 month ago
    WUSTL
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
    0:07:15

    Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL

    23 Views
    1 month ago
    WUSTL
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    BEACON Trial: What's Next? BEACON Trial: What's Next?
    0:02:57

    BEACON Trial: What's Next?

    11 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Phase 3 BEACON CRC Trial Phase 3 BEACON CRC Trial
    0:04:43

    Phase 3 BEACON CRC Trial

    70 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...

    Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...

    30 Views
    2 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login